Internal Medicine, Endocrinology, Diabetes, & Metabolism · Ocala, FL
NPI
1861694911
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1714 SW 17th St
Ocala, FL, 34471
Phone (352) 509-9900
Groups this clinician bills Medicare through
Medicare paid, 2024
$182K
5,680 services
Medicare patients, 2024
561
Average age 75
Drug cost, 2024
$4.5M
7,927 prescriptions
Company payments, 2025
$1,347
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lisa L Young was code J0897 (injection, denosumab, 1 mg), 1,740 times for 18 patients. In total Lisa L Young billed 5,680 services in 16 codes, and Medicare paid $182K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,740 | 18 | $20.69 | $36K |
| 99214 Office E&M - Established | Office | 961 | 431 | $92.03 | $88K |
| 95251 Test - Miscellaneous | Office | 486 | 184 | $25.51 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 371 | 242 | $12.48 | $4,629 |
| 83036 Blood Count | Office | 247 | 167 | $9.37 | $2,315 |
| 99213 Office E&M - Established | Office | 182 | 158 | $60.77 | $11K |
| 76536 Ultrasound - Nonspecific | Office | 108 | 100 | $75.26 | $8,128 |
| 99204 Office E&M - New | Office | 42 | 42 | $105.69 | $4,439 |
| 96372 Injection Administration | Office | 30 | 20 | $11.01 | $330 |
| 99203 Office E&M - New | Office | 18 | 18 | $58.78 | $1,058 |
| 96401 Chemotherapy Administration | Office | 13 | 13 | $53.83 | $700 |
By year: 2022 $149K for 3,210 services; 2023 $159K for 4,489 services; 2024 $182K for 5,680 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 247 | 167 | $9.37 | $2,315 |
Medicare prescription drug claims, 2024
In 2024, the drug Lisa L Young prescribed most often to Medicare patients was Ozempic (Semaglutide), with 540 prescriptions and refills. In total Lisa L Young wrote 7,927 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 540 | 795 | 128 | $753K |
| Levothyroxine Sodium Generic | 539 | 1,586 | 161 | $5,935 |
| Mounjaro Tirzepatide | 435 | 569 | 77 | $600K |
| Metformin Hcl Generic | 321 | 956 | 114 | $2,676 |
| Farxiga Dapagliflozin Propanediol | 265 | 672 | 89 | $367K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 240 | 520 | 94 | $39K |
| Glimepiride Generic | 199 | 576 | 69 | $2,441 |
| Jardiance Empagliflozin | 197 | 459 | 60 | $266K |
| Synthroid Levothyroxine Sodium | 186 | 472 | 47 | $15K |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 184 | 302 | 38 | $216K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 178 | 510 | 78 | $20K |
| Novolog Mix 70-30 Flexpen Insulin Aspart Prot/Insuln Asp | 168 | 320 | 39 | $68K |
| Metformin Hcl Er Metformin Hcl | 163 | 456 | 56 | $1,551 |
| Methimazole Generic | 157 | 459 | 48 | $1,928 |
| Atorvastatin Calcium Generic | 150 | 423 | 49 | $1,249 |
Brand drugs: 4,701 claims; generic drugs: 2,436 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lisa L Young $1,347 ($1,347 in general payments such as food, travel and fees) from 18 companies. The largest payer was Novo Nordisk Inc with $240.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 8 | $240 |
| Tandem Diabetes Care, Inc. TNDM | 10 | $193 |
| Amgen Inc. AMGN | 9 | $162 |
| Lilly USA, LLC LLY | 9 | $142 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $97.05 |
| Chiesi USA, Inc. | 4 | $89.69 |
| Xeris Pharmaceuticals, Inc. | 4 | $80.22 |
| Beta Bionics, Inc. BBNX | 3 | $59.05 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $51.15 |
| Madrigal Pharmaceuticals MDGL | 2 | $46.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.